08:00-09:00

Welcome & Registration

09:00-09:30

Opening Session

09:00-09:10

Opening Remarks
Dr. Ravit Geva, Chairperson, CTrials
Ms. Idit Chernovitz, CEO, Pharma Israel

Chair: Ms. Idit Chernovitz

09:10-09:20

Greetings
Rabbi Yakov Litzman, Minister of Health

09:20-09:30

Research as a Driving Force of the Israeli Economy
Dr. Janette Lazarovits, Deputy Head of the Life Science Department, Innovation Authority

09:30-09:40

A Bird's Eye View on Clinical Research
Ms. Liron Zohar,  Director of National Programs, Medical Technologies, Information and Research Division, Ministry of Health

Chair: Dr. Dan Goldstaub, Clinical Research Director, MSD

09:40-10:00

Upgrading Quality in Clinical Trials
What is the CMC (Chemistry, Manufacturing and Control) Section in Trial Submissions?
Ms. Stacy Malko, Assoc. Dir, Regulatory Affairs-CMC, CMC IND/CTA Department, MSD

10:00-10:15

The Investigational Medicinal Product Dossier
Dr. Catherine Ela, Director of the Clinical Trials Department, Ministry of Health
Dr. Ofra Axelrod, Director of the Institute for Standardization and Control of Pharmaceuticals, Ministry of Health

Chair: Dr. Moshe Neuman, President & CEO, Bio-Medical Research Design Ltd.

10:15-10:35

Launching the New Ministry of Health Website
Prof. Eyal Schwartzberg, Head of the Pharmaceutical Department, Ministry of Health

10:35-11:00

Coffee Break and Exhibition

11:00-12:30

Plenary Session: Research in the eHealth Era
Chair: Dr. Shany Blum

11:00-11:30

Transforming Clinical Trials with Technology  
Mr. Glen de Vries,  President & Co-Founder, Medidata Solutions

11:30-12:00

Panel Discussion: Clinical Research in the eHealth Era
Moderator: Dr. Shany Blum, MD PhD, Regulatory and Clinical Development Consulting

Panel participants:

Mr. Glen de Vries, Co-Founder & President, Medidata Solutions Inc.
Prof. Eyal Schwartzberg, Head of The Center for Pharmaceuticals & Enforcement, Ministry of Health
Dr. Dan Rapaport, CTO, MindUp
Mr. Guy Winograd, CEO, Softimize
Ms. Hagit Nof, COO & BD, nRollmed
Ms. Shlomit Cohen Ashkenazi, Camoni - a social network on health issues
Mr. Sharon Harris, CTO, Assuta Medical Centers

Chair: Mr. Asi Veshler, Vice President, Trialog clinical Trials

Nano Robots - Science (not so much ...) Fiction
Dr. Tom Ran, one of the leaders of the biological computer project at the Weizmann Institute of Science

Analytical Risk Based Monitoring
Chair:
Ms. Ayelet Levanon

Big Data
Chair:
Ms. Ilana Fishman

Advanced Drug Delivery Systems – From Macro to Micro and Nano
Chair:
Mr. Asi Veshler

Trends in the Pharmaceutical and Healthcare Industry: How are we doing and where can we improve
Mr. Eric Lang, MD
VP, Global Head Clinical Drug Development Strategists,
Covance Inc

Principles of Remote Monitoring
Ms. Ayelet Levanon
Associate Director Global Clinical Operation, J&J

Insights for Clinical Development From Big Data Perspective  
Mr. Glen de Vries
Co-Founder and President, Medidata Solutions Inc.

Good Distribution Practice in Clinical Trials
Rachel Shimonovitz
Head of the inspectorate Institute for Standardization
and Control of Pharmaceuticals

How to Create Value for Your Product (Drug/ Device) for Reimbursement by Health Authority
Ms. Marissa W. Fuller, MHS
Senior Director
Covance Market Access Services, Inc.

Panel Discussion:
ARBM
Participants:
The regulator:
Dr. Miriam Cohen-Kandli
Clinical Trials Control Manager, Ministry of Health
The Principle Investigator:
Dr. Avivit Peer
Director of Clinical Trials in Oncology, Rambam Health Care Campus
The Chairman of the Institutional Control Body:
Dr. Hadas Lamberg
Director Dept. of Research, Division of Research & Development,
Hadassah Medical Center
The Study Coordinator:
Ms. Limor Ben-Zvi
Coordinator, Research Unit, Oncology,
Sourasky Medical Center
The CRA:
Mr. Eric Kornblit
Monitor and project manager,
J&J

Big Data Could Build New Drugs Faster than Any Human Trial
Mr. Yigal Aviv
Product manager in emerging markets, Teva

Winners and Losers in the Medical Cannabis Industry
Dr. Tamir Gado
CEO, BOL Pharma

Intelligent Tools to Better Access patients in Clinical Trials
Ms. Irene Guz
Director of Clinical Operations & Country Head
Covance

Mr. Eric Lang, MD
VP, Global Head Clinical Drug Development Strategists
Covance Inc.

Optimization of Patient Targeting for Clinical Trials Based on the Maccabi Healthcare Services Database
Dr. Vered Eisenberg, MD, MHA
Director of Clinical Research, Maccabi Healthcare Services

Nanotherapeutics
from Macro to Micro Drug Delivery & Development
Dr. Michel Afargan
Director of Technology Development,
CTO, Nanomedicine I20 Pharma,
Senior Consultant to Drug Development

14:30-15:30